BIOEMTECH

At BIOEMTECH, we have an inherent passion for sharing knowledge. It is what drives us to organise our Annual Workshop and what made us aspire a specific science spot in our website, where someone can just read scientific reports and be scientifically updated on what is happening in the exciting field of Drug Discovery & Targeted Radioligand Therapy. This is why we are launching the Knowledge Hub 🧠 - each month we will be uploading a new "Science Letter" 👩🔬 , created by our collaborators, sponsors and team members. You can already read the first one, by Janke Kleynhans, on "Working with Actinium-225". 👉 https://lnkd.in/dmf4SeFh #ScienceLetters, #KnowledgeHub, #DrugDiscovery, #Radiopharmaceutics, #Actinium

In BIOEMTECH we are more than happy to contribute to this #HPC Training Series by EuroCC@Greece. Valentina Paneta and Vasilis Eleftheriadis will provide a #tutorial on "AI / DL in Healthcare Imaging -- Tutorial using MONAI and PyRadiomics". Don't miss the chance to attend the #training course on #AI in Healthcare and Life Sciences. 📅 Date: November 1st, 2024 📍Online🌐: Zoom ✍ Registration: Free #BIOEMTECH, #radiomics, #Deeplearning, #AI, #healthcare, #Pyradiomics, #MONAI

Small Size, Big Impact! 🧪 At just 44cm x 46cm, the γ-eye™ is your benchtop solution for advanced SPECT imaging. Turn any space into a cutting-edge lab! \#LabLife \#SPECTImaging Learn more: https://lnkd.in/gE6B_M4a

👩🔬 The 4th Annual BIOEMTECH's Preclinical Workshop drew to a close today with one last session on #Molecules. We would like to thank Theodoros Karampelas for his presentations and for moderating the panel discussion on “Targets & Therapies”, Jacob Hesterman and Olof Eriksson for their presentations, and finally Jeff Norenberg for joining in the panel discussion.   ✨ At the closing session there was a lot of excitement, and we committed to returning next year even more engaged in embracing scientists translate ideas into outcomes.   👏 A big round of applause to our workshop host, Katerina Argyropoulou, who kept everything running smoothly always with a smile on her face.   🍴 🍷 Before saying goodbye to all our attendees and speakers, we had the chance to have lunch and some farewell drinks, relax a little bit and chat, making our farewells a more memorable experience. This was a great week for us!   #preclinicalresearch #molecularimaging #drugdiscovery #pharmaceuticalresearch #nuclearmedicine #oncology #radiopharmaceuticals

🧑🎓 Today we delved deeper into subjects such as "Molecules in Drug Discovery and Regulatory" and "Operating Aspects of Preclinical/Clinical Studies" with 2 very interesting sessions. Each session was followed by a stimulating panel discussion on the crucial topic of “Choosing the right molecule” and the vital subject of “GLP & procedures”.   🙏 We would like to thank Jeff Norenberg for the opening presentation and for moderating the 1st panel discussion, Anne Bredenbeck, Federico Maisano for their nice presentations and SUJIET PUTHENVEETIL for participating in the panel discussion. We would also like to thank Irving Allen, Monique Bernsen for their presentations and finally Argyro Zacharioudaki for her presentation and moderation of the 2nd panel discussion.   🥂 We've got one last day of the 4th Annual BIOEMTECH's Preclinical Workshop tomorrow with one more #Molecules session on the agenda. After that, we'll have the closing ceremony with some farewell drinks. #preclinicalresearch #molecularimaging #drugdiscovery #pharmaceuticalresearch #nuclearmedicine #oncology #radiopharmaceuticals

🎊 3rd day of the 4th Annual BIOEMTECH’s Preclinical Workshop and today we had visitors in our Laboratories! It was a day full of hands-on experience and deep practical knowledge in #Radiation_protection, #Model_development, #Radio_compound_preparation, #Anesthesia_preparation, #Compound_administration and #Image_acquisition. 🤝 Special thanks to PD Dr. Felix Gremse, for his presentation on #Postprocessing. We are pleased to announce the forthcoming collaboration between Gremse-IT and BIOEMTECH, to provide state-of-the-art quantification analysis of preclinical imaging studies using #ImalyticsPreclinical software.   🔭 In the afternoon we had some time to relax with dinner and drinks in downtown Athens, followed by a guided tour of the National Observatory of Athens. Always take the opportunity to go stargazing...         #preclinicalresearch #molecularimaging #drugdiscovery #pharmaceuticalresearch #nuclearmedicine #oncology #radiopharmaceuticals

🎉 Today was the 2nd day of the 4th Annual BIOEMTECH's Preclinical Workshop and we continued to dive into the understanding and realisation of the major and most novel issues of the Drug and Radioligand Therapy field.     📅 The program started with the Isotopes & Cells session with Mattia Asti, Marion Malenge and Antonios Skliris. Then we had the Radiolabelling session with Janke Kleynhans and Sophia Sarpaki, PhD and our panel with Eliza Lambidis, PhD moderating. Finally, we had the Dosimetry session with Panagiotis Papadimitroulas, PD Dr. Felix Gremse and Dr. Michel Afargan with the closing lecture of the day. We would really like to thank all session speakers and panelists for their contributions.   🔬 Tomorrow is the Hands-On session! We look forward to welcoming all the workshop participants to our headquarters.     #preclinicalresearch #molecularimaging #drugdiscovery #pharmaceuticalresearch #nuclearmedicine #oncology #radiopharmaceuticals

🎉 The 4th Annual BIOEMTECH's Preclinical Workshop has started today, bringing together scientists from the Drug Discovery & Targeted Radioligand Therapy community. This will be a full week of inspiring talks and meaningful discussions with people from academia and industry in the field of drug discovery and targeted radioligand therapy.   🤝 Today we kicked off Workshop Day 1 with the Imaging Modalities and Non-Oncology Models sessions. We would like to thank Syed Nuruddin, PhD, Justin Jeffery, Thomas Wanek, Ingrid Yao Mattisson, PhD, Alice Zoro for their insightful presentations. Special thanks also to Pradip Chaudhari for moderating our panel discussion.   📰 We continue tomorrow with three more sessions: Isotopes & Cells, Radiolabelling and Dosimetry. Stay tuned...     #preclinicalresearch #molecularimaging #drugdiscovery #pharmaceuticalresearch #nuclearmedicine #oncology #radiopharmaceuticals

Last week took place the 1st SMARTdrugs symposium in #Raitenhaslach, Germany. BIOEMTECH is an industrial associated partner of SMARTdrugs project and our Science & Innovation Manager Maria Kitsara had the honor to participate as a speaker, sharing knowledge that springs from our experience in the field of radiotheranostics and molecular imaging. 📈 Her presentation was entitled “From Academia to Industry: Converting an Idea into a Product” and was an insightful overview of our company’s history as well as our expertise-core business in molecular imaging systems and services. 🤝 We are always happy to meet and collaborate with great scientists of the field, such as Angela Casini, Jason Holland, Jordi Llop, Alex Poot, Tim Witney, Kevin Brindle, Matt Morrison, Marco Cavaco - iMM Portugal, Marian Meckel - ITM Radiopharma and Mónica Carril García - UPV Spain. Moving forward to the amazing journey ahead!   #SMARTdrugs #EUproject #nuclearmedicine #radiotheranostics #radiopharmaceuticals #molecularimaging #oncology

Celebrating another #installation in Norway! A few days back, our team travelled to Oslo Imaging and Therapy Laboratory (OITL) to meet with the wonderful people (and scientists) of Norsk medisinsk syklotronsenter AS and Bayer Norge for the scope of a new γ eye installation! We would like to extend our gratitude towards everyone involved and impatiently awaiting for exciting results in research of targeted therapy in #cancer using alpha emitters like #Ac225, and conventional research in SPECT imaging probes. Bent Wilhelm Schoultz Syed Nuruddin, PhD Sepehr Teimouri Ana Oteiza gebregziabher Petros Antónis Gkikas Sofia Lagoumtzi Michalis Asprogerakas Read more about the only system that can efficiently image alpha emitting isotopes, in vivo, here: https://lnkd.in/dk3BCzuC #preclinicalresearch #SPECT #radiopharmaceuticals #nuclearmedicine #targetedtherapy